Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial
Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label updated from v3.6.4 to v3.6.5, reflecting a new site build rather than changes to the trial record.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision entry, Revision: v3.6.4, has been added to the study record history, replacing the previous revision. This indicates a system or UI update to the page without changes to the study data.SummaryDifference0.1%

- Check46 days agoChange DetectedRecord history now lists Revision: v3.6.3, replacing the previous Revision: v3.6.2 in the version entries. This reflects an update to the history metadata on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedA new page revision entry (v3.6.2) was added to the Record History, replacing the previous (v3.6.0). This update reflects a version change in the page rather than a change to study data or results.SummaryDifference0.1%

- Check67 days agoChange DetectedThe study record now indicates recruitment is closed (no longer looking for participants), and the history shows a new revision (v3.6.0) added with the previous revision (v3.5.5) removed.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded Revision: v3.5.5 to the history and removed Revision: v3.5.4 from the record.SummaryDifference0.1%

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.